$Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocardial revascularization$

Prediction role of a novel biomarker ST2 in risk assessment of adverse cardiovascular events in chronic heart failure with preserved and intermediate ejection fraction after myocardial revascularization

Aim. To evaluate prediction role of the biomarkers soluble ST2 (sST2) and natriuretic hormone N-terminal propeptide (NT-proBNP) in risk assessment of adverse cardiovascular events (ACVE) in coronary heart disease patients (CHD) with chronic heart failure (CHF) after myocardial revascularization.Mate...

Full description

Bibliographic Details
Main Authors:	E. V. Grakova, A. T. Teplyakov, K. V. Kopieva, Sh. D. Akhmedov, O. N. Ogurkova, M. V. Soldatenko
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2018-10-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	ишемическая болезнь сердца реваскуляризация миокарда неблагоприятные сердечно-сосудистые события прогнозирование биомаркеры сердечная недостаточность
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/755

Similar Items

Clinical use of the new biomarker ST2 in patients with chronic heart failure of ischemic genesis: an exercise test
by: E. V. Grakova, et al.
Published: (2019-09-01)

Valid cardiac biochemical markers. Part II
by: N. G. Gumanova, et al.
Published: (2020-11-01)

EVALUATION OF MYOCARDIAL REVASCULARIZATION IN STABLE CORONARY HEART DISEASE PATIENTS AND FACTORS ASSOCIATED WITH INVASIVE STRATEGY CHOICE
by: A. S. Korotin, et al.
Published: (2017-08-01)

Meta-analyses and systematic reviews on myocardial revascularization: comparing survival, myocardial infarction, repeated revascularization and angina symptom reduction rates
by: I. V. Samorodskaya
Published: (1970-01-01)

Prognosis of cardiovascular events after implantation of a cardioverterdefibrillator in patients with chronic heart failure: the value of increasing concentration of endothelin-1 and soluble forms of ST2 protein in blood plasma
by: A. T. Teplyakov, et al.
Published: (2018-09-01)

Analysis of myocardial revascularization and endpoints after a 1-year follow-up of patients with acute and chronic coronary artery disease, depending on diabetes presence
by: M. N. Mamedov, et al.
Published: (2022-11-01)

CARBOHYDRATE METABOLISM DISORDERS AND CORONARY HEART DISEASE: PROGNOSTIC VALUE AND REVASCULARISATION EFFECTIVENESS
by: L. V. Kremneva, et al.
Published: (2013-06-01)

Valid cardiac biomarkers. Part I
by: V. A. Metelskaya, et al.
Published: (2020-09-01)

Mozhno li uspeshno lechit' bol'nykh ishemicheskoy bolezn'yu serdtsa v sochetanii s sakharnym diabetom?
by: Yury Alexandrovich Karpov
Published: (2002-12-01)

Myocardial revascularization in patients with multivessel coronary lesions
by: Л. С. Калугина, et al.
Published: (2016-11-01)

Residual risk in patients with atherosclerotic cardiovascular disease
by: E. V. Khazova, et al.
Published: (2023-02-01)

Prognostic significance of atherosclerosis of one or two vascular systems in patients with high and very high cardiovascular risk
by: V. V. Genkel, et al.
Published: (2021-03-01)

EARLY MARKERS OF PROGRESSION OF HEART FAILURE AND APOPTOSIS: THEIR ROLE IN PREDICTING THE RISK OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION
by: A. T. Teplyakov, et al.
Published: (2016-03-01)

Adherence to therapy and the risk of cardiovascular events in patients with heart failure: data from the outpatient registry
by: E. T. Guseinova, et al.
Published: (2022-11-01)

Outcomes of single-stage prosthetic repair of the ascending aorta and myocardial revascularization
by: Ю. В. Белов, et al.
Published: (2015-10-01)

Minimally invasive myocardial revascularization in left coronary artery trunk pathology: safety, efficacy, and clinical results
by: M. V. Zhelikhazheva, et al.
Published: (2005-10-01)

Radiofrequency transmyocardial revascularization in experiment
by: A. I. Opherkin, et al.
Published: (2002-09-01)

Артериальная реваскуляризация миокарда с использованием Y-композитных конструкций и in situ кондуитов внутренних грудных артерий: непосредственные результаты
by: А. Сабетов, et al.
Published: (2020-12-01)

ANALYSIS OF LONG TERM RESULTS OF MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE WITH A HIGH LEVEL OF TREATMENT ADHERENCE
by: N. Yu. Sokolova, et al.
Published: (2017-08-01)

Prognostic role of metabolic risk factors (hyperhomocysteinemia) in the development of chronic heart failure
by: Е. Н. Березикова, et al.
Published: (2015-10-01)

A COMPLEX ASSESSMENT OF COMBINATION DRUG THERAPY IN CARDIOVASCULAR COMORBIDITY
by: Yu. V. Luneva, et al.
Published: (2016-08-01)

CD40 ligand level – vascular inflammation activity and long6term prognosis in coronary heart disease patients
by: O. P. Shevchenko, et al.
Published: (2008-02-01)

ОСТРЫЙ КОРОНАРНЫЙ СИНДРОМ: КОМПЛЕКСНЫЙ ВЗГЛЯД НА ПРОБЛЕМУ, ЗНАЧЕНИЕ ГОСПИТАЛЬНОГО И АМБУЛАТОРНОГО ЭТАПОВ ЛЕЧЕНИЯ ПАЦИЕНТОВ
by: И. С. Скопец, et al.
Published: (2012-06-01)

Chronic heart failure in out-patient practice: aetiology issues
by: S. M. Bogdanova, et al.
Published: (2008-08-01)

METABOLOMIC APPROACHES IN STUDYING OF CARDIOVASCULAR DISEASES
by: A. A. Аbdullaev, et al.
Published: (2021-03-01)

Анализ непосредственных результатов повторного коронарного шунтирования
by: М. Гордеев, et al.
Published: (2021-04-01)

Myocardial revascularization effects on vascular endothelial growth factor and transforming growth factor β-1 in coronary heart disease patients
by: I. V. Sergienko, et al.
Published: (2007-10-01)

Eurasian Guidelines for the diagnostics and management of stable coronary artery disease (2020-2021)
by: Yu. A. Karpov, et al.
Published: (2021-09-01)

Perioperative Hemostatic Features in Patients with Acute Coronary Syndrome and Chronic Coronary Heart Disease
by: Yu. V. Nikiforov, et al.
Published: (2007-08-01)

Trimetazidine MB treatment in patients with chronic heart failure
by: T. E. Morozova, et al.
Published: (2010-06-01)

Prospective rAndomized, single-blind, mulTicenter control clinical study of sirolimus-eluting coRonary stent “Calypso” vs everolimus-elutIng cOronary stenT “Xience Prime”: design and rationale for “PATRIOT” trial
by: А. А. Прохорихин, et al.
Published: (2016-12-01)

OBSTRUCTIVE CORONARY ATHEROSCLEROSIS AND ISCHEMIC HEART DISEASE: AN ELUSIVE LINK!
by: M. Marzilli, et al.
Published: (2015-12-01)

Physical rehabilitation and endothelial dysfunction in coronary heart disease
by: V. A. Margazin, et al.
Published: (2006-02-01)

DOES THE “OBESITY PARADOX” REALLY TAKE PLACE IN CORONARY HEART DISEASE?
by: O. M. Drapkina, et al.
Published: (2016-08-01)

Nutrition as one of the important factors in prevention and treatment of atherosclerotic cardiovascular diseases
by: I. V. Rudchenko, et al.
Published: (2020-07-01)

The results of standard echocardiography and use of Velocity Vector Imaging technology after surgical revascularization in patients with coronary artery disease
by: A. Yu. Vasiliev, et al.
Published: (2019-08-01)

Anxiety states in cardiac patients: diagnostics and treatment aspects
by: G. V. Pogosova
Published: (2006-10-01)

IVABRADINE INFLUENCE ON SYSTOLIC AND DIASTOLIC FUNCTION OF HEART VENTRICLES IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER PRIMARY REVASCULARIZATION
by: N. V. Drobotya, et al.
Published: (2014-10-01)

Prevention of cardiovascular events in patients with stable coronary artery disease: myocardial revascularization or pharmacological treatment?
by: I. S. Yavelov
Published: (2021-05-01)

3-year outcomes of endocardial implantation of autologous bone marrow mononuclear cells in cad patients with normal ejection fraction value
by: А. М. Чернявский, et al.
Published: (2015-10-01)